Bufexamac: a review of its pharmacological properties and therapeutic efficacy in inflammatory dermatoses.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002019:Bufexamac / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D003872:Dermatitis / Q000188:drug therapy*; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology*; D007700:Kinetics; D012869:Skin Absorption; D014945:Wound Healing / Q000187:drug effects
D000893:Anti-Inflammatory Agents; D006877:Hydroxamic Acids; D002019:Bufexamac